Outcome measures are the foundation of effective clinical research. They define how we understand disease, track progression, and evaluate whether a therapy is making a real difference in the lives of individuals and families. At COMBINEDBrain, we are building a coordinated, cross-disease framework for outcome measurement—designed to reflect real-world impact, support clinical trial readiness, and enable comparison across rare neurodevelopmental disorders. What we measure determines what we learn—and ultimately, what treatments reach patients.

We develop and organize outcome measures across three complementary domains:

1. Disease Understanding

We define how each condition manifests and evolves through Disease Concept Models, capturing the full lived experience—from core symptoms to functional impact.

2. Patient-Centered Measurement

We design and deploy targeted tools—such as caregiver-reported surveys—to capture outcomes that matter most in daily life, including:

• Toileting independence (ORTAS)
• Communication abilities (ORCA)

3. Clinical Trial Alignment

We compile and analyze outcome measures currently used in clinical trials, enabling:

• Cross-study comparison
• Identification of gaps
• Standardization opportunities across disorders

Integration with COMBINEDBrain Infrastructure

Outcome measures are not developed in isolation—they are integrated across the COMBINEDBrain ecosystem:

• MATRIX Platform → standardized data collection and longitudinal tracking
• Biorepository → linkage of clinical outcomes with biospecimens and biomarkers
• Collaborative Network → input from patient advocacy groups, clinicians, and industry

Together, this creates a connected data environment where clinical, biological, and functional outcomes can be analyzed in context—supporting deeper insights and more effective therapeutic development.